Meyer B J, Chesebro J H
University Hospital, Berne, Switzerland.
Curr Opin Hematol. 1994 Sep;1(5):336-40.
Prevention of thrombus formation and embolization remains a therapeutic challenge. Recent advances in the treatment of arterial thromboembolic disease include prevention of thromboembolism in patients with nonrheumatic atrial fibrillation with warfarin or aspirin, and combined therapy with low-dose aspirin, and anticoagulants for prosthetic heart valves and coronary artery disease. The potential of direct thrombin inhibition for treatment of acute coronary syndromes is also discussed.
预防血栓形成和栓塞仍然是一项治疗挑战。动脉血栓栓塞性疾病治疗的最新进展包括使用华法林或阿司匹林预防非风湿性心房颤动患者的血栓栓塞，以及低剂量阿司匹林与抗凝剂联合治疗人工心脏瓣膜和冠状动脉疾病。还讨论了直接凝血酶抑制在治疗急性冠状动脉综合征方面的潜力。
